Before revision:  Motivated by the fact that drug synergy is closely tied with biological targets, we propose a  model that jointly learns drug-target interaction and drug synergy.
After revision:  Motivated by the fact that drug synergy is closely tied with biological targets, we propose a biological bottleneck model that jointly learns drug-target interaction and drug synergy.